Biblio

Found 61 results
Author Keyword Title [ Type(Desc)] Year
Journal Article
F. R. Sattler, He, J., Letendre, S., Wilson, C., Sanders, C., Heaton, R., Ellis, R., Franklin, D., Aldrovandi, G., Marra, C. M., Clifford, D., Morgello, S., Grant, I., and J McCutchan, A., Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation., J Acquir Immune Defic Syndr, vol. 68, no. 3, pp. 281-8, 2015.
D. B. Clifford, Vaida, F., Kao, Y. - T., Franklin, D. R., Letendre, S. L., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Grant, I., and Heaton, R. K., Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people., Neurology, vol. 84, no. 3, pp. 241-50, 2015.
E. E. Morgan, Woods, S. P., Letendre, S. L., Franklin, D. R., Bloss, C., Goate, A., Heaton, R. K., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Ellis, R. J., Abramson, I., Gamst, A., Fennema-Notestine, C., Smith, D. M., Grant, I., Vaida, F., and Clifford, D. B., Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders., J Neurovirol, vol. 19, no. 2, pp. 150-6, 2013.
J. Robinson-Papp, Morgello, S., Vaida, F., Fitzsimons, C., Simpson, D. M., Elliott, K. J., Al-Lozi, M., Gelman, B. B., Clifford, D., Marra, C. M., McCutchan, J. A., Atkinson, J. H., Dworkin, R. H., Grant, I., and Ellis, R., Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy., Pain, vol. 151, no. 3, pp. 732-6, 2010.
I. Grant, Franklin, D. R., Deutsch, R., Woods, S. P., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Smith, D. M., and Heaton, R. K., Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline., Neurology, vol. 82, no. 23, pp. 2055-62, 2014.
S. L. Archibald, McCutchan, J. A., Sanders, C., Wolfson, T., Jernigan, T. L., Ellis, R. J., Ances, B. M., Collier, A. C., McArthur, J. C., Morgello, S., Simpson, D. M., Marra, C., Gelman, B. B., Clifford, D. B., Grant, I., and Fennema-Notestine, C., Brain morphometric correlates of metabolic variables in HIV: the CHARTER study., J Neurovirol, vol. 20, no. 6, pp. 603-11, 2014.
R. J. Ellis, Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., Clifford, D., Collier, A. C., Gelman, B., McArthur, J., Morgello, S., J McCutchan, A., and Grant, I., CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy., AIDS, vol. 25, no. 14, pp. 1747-51, 2011.
E. R. Hammond, Crum, R. M., Treisman, G. J., Mehta, S. H., Marra, C. M., Clifford, D. B., Morgello, S., Simpson, D. M., Gelman, B. B., Ellis, R. J., Grant, I., Letendre, S. L., and McArthur, J. C., The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV., Am J Epidemiol, vol. 180, no. 3, pp. 297-307, 2014.
B. Biswas, Spitznagel, E., Collier, A. C., Gelman, B. B., McArthur, J. C., Morgello, S., McCutchan, J. A., and Clifford, D. B., Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort., J HIV AIDS Soc Serv, vol. 13, no. 1, pp. 8-25, 2014.
T. L. Jernigan, Archibald, S. L., Fennema-Notestine, C., Taylor, M. J., Theilmann, R. J., Julaton, M. D., Notestine, R. J., Wolfson, T., Letendre, S. L., Ellis, R. J., Heaton, R. K., Gamst, A. C., Franklin, D. R., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C., McArthur, J. C., J McCutchan, A., Morgello, S., Simpson, D. M., and Grant, I., Clinical factors related to brain structure in HIV: the CHARTER study., J Neurovirol, vol. 17, no. 3, pp. 248-57, 2011.
A. R. Bharti, Letendre, S. L., Wolfson, T., Clifford, D., Collier, A. C., Gelman, B., McArthur, J., Marra, C., McCutchan, A., Morgello, S., Simpson, D., Ellis, R. J., and Grant, I., Clinical variables identify seronegative HCV co-infection in HIV-infected individuals., J Clin Virol, vol. 52, no. 4, pp. 328-32, 2011.
I. Perez-Valero, Cysique, L., Letendre, S., and Heaton, R., Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy"., HIV Clin Trials, vol. 13, no. 5, pp. 296-8; author reply 299-300, 2012.
M. Ferrara, Umlauf, A., Sanders, C., Meyer, J. M., McCutchan, J. Allen, Duarte, N., Atkinson, J. Hampton, Grant, I., and Ellis, R. J., The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk., Psychiatry Res, vol. 218, no. 1-2, pp. 201-8, 2014.
M. Sakamoto, Marcotte, T. D., Umlauf, A., Franklin, D., Heaton, R. K., Ellis, R. J., Letendre, S., Alexander, T., McCutchan, J. A., Morgan, E. E., Woods, S. P., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D., and Grant, I., Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort., J Acquir Immune Defic Syndr, vol. 62, no. 1, pp. 36-42, 2013.
R. J. Ellis, Rosario, D., Clifford, D. B., McArthur, J. C., Simpson, D., Alexander, T., Gelman, B. B., Vaida, F., Collier, A., Marra, C. M., Ances, B., J Atkinson, H., Dworkin, R. H., Morgello, S., and Grant, I., Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study., Arch Neurol, vol. 67, no. 5, pp. 552-8, 2010.
A. M. Anderson, Fennema-Notestine, C., Umlauf, A., Taylor, M. J., Clifford, D. B., Marra, C. M., Collier, A. C., Gelman, B. B., McArthur, J. C., J McCutchan, A., Simpson, D. M., Morgello, S., Grant, I., and Letendre, S. L., CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease., J Neurovirol, vol. 21, no. 5, pp. 559-67, 2015.
D. Croteau, Rossi, S. S., Best, B. M., Capparelli, E., Ellis, R. J., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C. M., McArthur, J., J McCutchan, A., Morgello, S., Simpson, D. M., Grant, I., and Letendre, S., Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration., J Antimicrob Chemother, vol. 68, no. 3, pp. 684-9, 2013.
K. Blackstone, Moore, D. J., Franklin, D. R., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Ellis, R. J., Atkinson, J. H., Grant, I., and Heaton, R. K., Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings., Clin Neuropsychol, vol. 26, no. 6, pp. 894-908, 2012.
K. Blackstone, Moore, D. J., Heaton, R. K., Franklin, D. R., Woods, S. P., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Rivera-Mindt, M., Deutsch, R., Ellis, R. J., J Atkinson, H., and Grant, I., Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning., J Int Neuropsychol Soc, vol. 18, no. 1, pp. 79-88, 2012.
B. M. Best, Koopmans, P. P., Letendre, S. L., Capparelli, E. V., Rossi, S. S., Clifford, D. B., Collier, A. C., Gelman, B. B., Mbeo, G., J McCutchan, A., Simpson, D. M., Haubrich, R., Ellis, R., and Grant, I., Efavirenz concentrations in CSF exceed IC50 for wild-type HIV., J Antimicrob Chemother, vol. 66, no. 2, pp. 354-7, 2011.
K. Lin, Taylor, M. J., Heaton, R., Franklin, D., Jernigan, T., Fennema-Notestine, C., McCutchan, A., J Atkinson, H., Ellis, R. J., McArthur, J., Morgello, S., Simpson, D., Collier, A. C., Marra, C., Gelman, B., Clifford, D., and Grant, I., Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals., J Clin Exp Neuropsychol, vol. 33, no. 3, pp. 326-34, 2011.
T. H. Burdo, Weiffenbach, A., Woods, S. P., Letendre, S., Ellis, R. J., and Williams, K. C., Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection., AIDS, vol. 27, no. 9, pp. 1387-95, 2013.
A. Nguyen, Rossi, S., Croteau, D., Best, B. M., Clifford, D., Collier, A. C., Gelman, B., Marra, C., McArthur, J., J McCutchan, A., Morgello, S., Simpson, D., Ellis, R. J., Grant, I., Capparelli, E., and Letendre, S., Etravirine in CSF is highly protein bound., J Antimicrob Chemother, vol. 68, no. 5, pp. 1161-8, 2013.
D. J. Moore, Arce, M., Moseley, S., J McCutchan, A., Marquie-Beck, J., Franklin, D. R., Vaida, F., Achim, C. L., McArthur, J., Morgello, S., Simpson, D. M., Gelman, B. B., Collier, A. C., Marra, C. M., Clifford, D. B., Heaton, R. K., and Grant, I., Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons., J Neuropsychiatry Clin Neurosci, vol. 23, no. 3, pp. 316-23, 2011.
J. Yong Choi, Hightower, G. K., Wong, J. K., Heaton, R., Woods, S., Grant, I., Marcotte, T. D., Ellis, R. J., Letendre, S. L., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., J McCutchan, A., Richman, D. D., and Smith, D. M., Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat., J Neurovirol, vol. 18, no. 2, pp. 81-90, 2012.

Pages